Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Harmony Biosciences Holdings

Harmony Biosciences
Regional

Harmony Biosciences Delivers Strong Q2 Growth, Advances Late-Stage Pipeline

August 11, 2025August 8, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) reported another quarter of double-digit revenue growth and solidified its position as a profitable, late-stage biotech leader, driven by continued momentum …

Harmony Biosciences Delivers Strong Q2 Growth, Advances Late-Stage Pipeline Read More

Harmony Biosciences
Regional

Harmony Biosciences to Announce Q2 2025 Financial Results on August 5

July 28, 2025July 26, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) is scheduled to announce its financial results for the second quarter of 2025 on Tuesday, August 5, 2025, prior to …

Harmony Biosciences to Announce Q2 2025 Financial Results on August 5 Read More
Harmony Biosciences
Regional

Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment

June 16, 2025June 15, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences recently revealed compelling preclinical data for BP1.15205, a highly potent and selective orexin 2 receptor (OX2R) agonist, at the 39th Annual Meeting of the …

Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment Read More

Harmony Biosciences
Regional

Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation

June 9, 2025June 8, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently announced the resolution of its patent litigation against Lupin Limited regarding a generic version of WAKIX® (pitolisant hydrochloride). The …

Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation Read More
Harmony Biosciences
Regional

Harmony Biosciences to Join Fireside Chat at Goldman Sachs Global Healthcare Conference

June 8, 2025June 7, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences (Nasdaq: HRMY) announced its management team will join a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami, FL, on …

Harmony Biosciences to Join Fireside Chat at Goldman Sachs Global Healthcare Conference Read More

Harmony Biosciences
Regional

Harmony Biosciences Presents Positive Data on ZYN002 for Fragile X Syndrome

April 14, 2025April 14, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) unveiled promising results from its Open-Label Extension (OLE) study evaluating ZYN002, a potential treatment for Fragile X syndrome (FXS). The …

Harmony Biosciences Presents Positive Data on ZYN002 for Fragile X Syndrome Read More
Harmony Biosciences
Regional

Harmony Biosciences Appoints Ron Philip to Board of Directors

April 8, 2025April 7, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced the addition of Ron Philip, President and CEO of Orbital Therapeutics, to its Board of Directors. Philip brings …

Harmony Biosciences Appoints Ron Philip to Board of Directors Read More

Harmony Biosciences
Regional

Harmony Biosciences to Present at 24th Annual Needham Virtual Healthcare Conference

March 31, 2025March 30, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced that its management team will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. …

Harmony Biosciences to Present at 24th Annual Needham Virtual Healthcare Conference Read More
Harmony Biosciences
Regional

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer

March 30, 2025March 30, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced the appointment of Adam Zaeske as its new Executive Vice President and Chief Commercial Officer (CCO), effective March 31, …

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer Read More
Harmony Biosciences
Regional

Harmony Biosciences to Present at Upcoming Global Healthcare Conferences

March 10, 2025March 9, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced its participation in two upcoming investor conferences.

Harmony Biosciences to Present at Upcoming Global Healthcare Conferences Read More

Posts pagination

1 2 3 Next

Trending News

  • Circus Campus Brings Three Weeks of Big Top Spectacle to Philadelphia Fringe Festival

  • Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio

  • High-Speed Stop in Edgemoor Leads to Arrest of Two and Seizure of Loaded Guns, Police Say

  • Christian Employers Alliance Pushes FAIR Act to Curb Political Influence in Utility Rate Decisions

  • Police Chase Through East Lansdowne Ends in Crashes, Injuries, and Arrest of Upper Darby Man

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Bre’yanah Coleman-Davis and Wanya Wray

High-Speed Stop in Edgemoor Leads to Arrest of Two and Seizure of Loaded Guns, Police Say

August 15, 2025August 15, 2025

Darius Javon Wheeler

Police Chase Through East Lansdowne Ends in Crashes, Injuries, and Arrest of Upper Darby Man

August 15, 2025August 15, 2025

Gouley Park vandalism

Police Seek Teens Accused of Setting Fire to Newly Built Turf Field in Nether Providence

August 15, 2025August 15, 2025

Copyright © 2025 MyChesCo.